BOEHRINGER INGELHEIM PHARMACEUTICALS INC. et al v. PRINSTON PHARMACEUTICAL INC. et al > Summary
Court Case Number 3:16-cv-00851
Filing Date Feb 17, 2016
Termination Date Mar 17, 2016
Court New Jersey District Court
Status Unknown
Plaintiff Attorneys
12Boehringer Ingelheim International GmbH
Attorney Name: Christopher J. Borchert
Connell Foley
Boehringer Ingelheim International GmbH
Attorney Name: Christopher J. Borchert
Connell Foley
Boehringer Ingelheim International GmbH
Attorney Name: Christopher J. Borchert
Connell Foley
Boehringer Ingelheim International GmbH
Attorney Name: Christine I. Gannon
Connell Foley
Boehringer Ingelheim International GmbH
Attorney Name: Christine I. Gannon
Connell Foley
Boehringer Ingelheim International GmbH
Attorney Name: Christine I. Gannon
Connell Foley
Boehringer Ingelheim International GmbH
Attorney Name: Christine I. Gannon
Connell Foley
Boehringer Ingelheim International GmbH
Attorney Name: Liza M. Walsh
Connell Foley
Boehringer Ingelheim International GmbH
Attorney Name: Liza M. Walsh
Connell Foley
Boehringer Ingelheim International GmbH
Attorney Name: Liza M. Walsh
Connell Foley
Boehringer Ingelheim International GmbH
Attorney Name: Liza M. Walsh
Connell Foley
Defendant Attorneys
2Prinston Pharmaceutical Inc.
Attorney Name: Eric I. Abraham
Hill Wallack LLP
Cause
35:271 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 08846695 | Treatment for diabetes in patients with inadequate glycemic control despite metformin therapy comprising a DPP-IV inhibitor | Sep 30, 2014 |
| 08673927 | Uses of DPP-IV inhibitors | Mar 18, 2014 |
